SLNO
Price
$46.88
Change
+$0.89 (+1.94%)
Updated
Jan 17 closing price
Capitalization
2.02B
66 days until earnings call
XENE
Price
$38.52
Change
-$1.10 (-2.78%)
Updated
Jan 17 closing price
Capitalization
2.94B
39 days until earnings call
Ad is loading...

SLNO vs XENE

Header iconSLNO vs XENE Comparison
Open Charts SLNO vs XENEBanner chart's image
Soleno Therapeutics
Price$46.88
Change+$0.89 (+1.94%)
Volume$348.37K
Capitalization2.02B
Xenon Pharmaceuticals
Price$38.52
Change-$1.10 (-2.78%)
Volume$469.48K
Capitalization2.94B
SLNO vs XENE Comparison Chart
Loading...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLNO vs. XENE commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLNO is a Hold and XENE is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (SLNO: $46.88 vs. XENE: $38.52)
Brand notoriety: SLNO and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLNO: 55% vs. XENE: 113%
Market capitalization -- SLNO: $2.02B vs. XENE: $2.94B
SLNO [@Biotechnology] is valued at $2.02B. XENE’s [@Biotechnology] market capitalization is $2.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLNO’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 2 green FA rating(s).

  • SLNO’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 2 green, 3 red.
According to our system of comparison, XENE is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLNO’s TA Score shows that 4 TA indicator(s) are bullish while XENE’s TA Score has 4 bullish TA indicator(s).

  • SLNO’s TA Score: 4 bullish, 4 bearish.
  • XENE’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, XENE is a better buy in the short-term than SLNO.

Price Growth

SLNO (@Biotechnology) experienced а +8.75% price change this week, while XENE (@Biotechnology) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

SLNO is expected to report earnings on May 13, 2025.

XENE is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XENE($2.94B) has a higher market cap than SLNO($2.02B). SLNO YTD gains are higher at: 4.294 vs. XENE (-1.735). SLNO has higher annual earnings (EBITDA): -136.5M vs. XENE (-252.74M). XENE has more cash in the bank: 654M vs. SLNO (257M). SLNO has less debt than XENE: SLNO (3.03M) vs XENE (9.79M). SLNO (0) and XENE (0) have equivalent revenues.
SLNOXENESLNO / XENE
Capitalization2.02B2.94B69%
EBITDA-136.5M-252.74M54%
Gain YTD4.294-1.735-248%
P/E RatioN/AN/A-
Revenue00-
Total Cash257M654M39%
Total Debt3.03M9.79M31%
FUNDAMENTALS RATINGS
SLNO vs XENE: Fundamental Ratings
SLNO
XENE
OUTLOOK RATING
1..100
556
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
6417
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
6075
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XENE's Valuation (97) in the Biotechnology industry is in the same range as SLNO (99) in the Medical Specialties industry. This means that XENE’s stock grew similarly to SLNO’s over the last 12 months.

XENE's Profit vs Risk Rating (17) in the Biotechnology industry is somewhat better than the same rating for SLNO (64) in the Medical Specialties industry. This means that XENE’s stock grew somewhat faster than SLNO’s over the last 12 months.

XENE's SMR Rating (95) in the Biotechnology industry is in the same range as SLNO (98) in the Medical Specialties industry. This means that XENE’s stock grew similarly to SLNO’s over the last 12 months.

SLNO's Price Growth Rating (60) in the Medical Specialties industry is in the same range as XENE (75) in the Biotechnology industry. This means that SLNO’s stock grew similarly to XENE’s over the last 12 months.

XENE's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for SLNO (100) in the Medical Specialties industry. This means that XENE’s stock grew significantly faster than SLNO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLNOXENE
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
88%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
80%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
76%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
80%
View a ticker or compare two or three
Ad is loading...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with XENE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+1.94%
XENE - SLNO
40%
Loosely correlated
-2.78%
KYMR - SLNO
40%
Loosely correlated
+0.79%
SVRA - SLNO
40%
Loosely correlated
+0.69%
GRCE - SLNO
38%
Loosely correlated
+8.93%
SPRY - SLNO
38%
Loosely correlated
+3.20%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
-2.78%
KYMR - XENE
47%
Loosely correlated
+0.79%
CRNX - XENE
44%
Loosely correlated
+2.38%
RCKT - XENE
44%
Loosely correlated
+0.98%
PLRX - XENE
44%
Loosely correlated
-3.36%
AURA - XENE
43%
Loosely correlated
+1.30%
More